JeeSuk Chang
@changjeesuk1
Associate Professor @Yonsei, Seoul, Korea
ID: 2533612502
https://pubmed.ncbi.nlm.nih.gov/?term=jee+suk+chang&sort=date 29-05-2014 23:24:53
1,1K Tweet
769 Followers
585 Following
Hot off the press in IJROBP - The Red Journal: the ARREST phase I trial of SABR in poly-metastatic disease, led by Glenn Bauman, MD & Tim Nguyen Average number of lesions = 16 Dose safely escalated to 30 Gy in 5 fractions. sciencedirect.com/science/articl… The phase II/III RCT ARREST2 is underway!
🔥Hot off the press European Urology Oncology IROCK 🇨🇦🇦🇺🇺🇸🇩🇪🇯🇵 demonstrating #SABR ⚡️yields moderate long-term renal function decline, low dialysis rates even in patients with a solitary kidney #radonc authors.elsevier.com/c/1jOzs9Cfv--d… Thankful for mentors Shankar Siva Alex Louie MD, PhD Rohann Correa
#AI is taking over OAR contouring. To ensure a safe transition from manual to AI contouring, we need agreed definitions. The #DAHANCA group revised OAR guidelines and quantified 3D contouring variation: shorturl.at/Iu3gj 3D OARs: shorturl.at/x024T Chr Rønn Hansen
Generating 3D images of VMAT plans for predictive models and activation maps associated with plan deliverability #Yonsei #MP🇰🇷 American Association of Physicists in Medicine pubmed.ncbi.nlm.nih.gov/38978162/
Prospective study showing no difference in cosmetic outcome with hypofractionation for PMRT and implant #bcsm Chirag Shah Erin Gillespie, MD MPH jamanetwork.com/journals/jamao…
The EXTEND 🪜 #Ph2 trial in Journal of Clinical Oncology show that adding metastasis-directed therapy (MDT) to 💉 ⬆️ #PFS in oligometastatic #pancsm suggesting systemic immunity 🛡️as a potential mechanism. #GIonc OncoAlert🚨 Elisabetta Bonzano MD, PhD Gil Morgan, MD Aakash Desai, MD, MPH ascopubs.org/doi/10.1200/JC…
Randomized phase II STOP trial of SBRT for oligoprogressive cancer - 127 pts - 3.4% G3 tox, no G4/5 tox - No difference in PFS: median 8.4mo (SBRT) vs 4.3 mo (SoC) - HOWEVER, protocol adherence suboptimal, 35% in SoC treated with SBRT or study withdrawal redjournal.org/article/S0360-…
☢️ Systematic review and meta-analysis of SABR in oligoprogression published in Radiotherapy & Oncology authors.elsevier.com/c/1jkuTcA0-IX1E Joelle Dr. David Palma Aisling Barry Jacques Raphael